Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Vasiliki Stravokefalou
Observed name:
Stravokefalou, Vasiliki
Institution:
University of Thessaly
Observed institutions:
University of Thessaly,
National Hellenic Research Foundation,
Frederick National Laboratory for Cancer Research,
National Cancer Institute,
Center for Cancer Research
ORCID:
0000-0002-1205-5805
Observed ORCID:
0000-0002-1205-5805
OpenAlex ID:
A5086660875
Heterodimeric IL-15 in Cancer Immunotherapy
2021
·
Cristina Bergamaschi
, Vasiliki Stravokefalou
, et al.
·
Cancers
·
55
PDF
Heterodimeric IL-15 (hetIL-15) reduces circulating tumor cells and metastasis formation improving chemotherapy and surgery in 4T1 mouse model of TNBC
2023
·
Vasiliki Stravokefalou
, Dimitris Stellas
, et al.
·
Frontiers in Immunology
·
26
A GATA2-CDC6 axis modulates androgen receptor blockade-induced senescence in prostate cancer
2023
·
Ioanna Mourkioti
, Aikaterini Polyzou
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
23
PDF
Tumor eradication by hetIL-15 locoregional therapy correlates with an induced intratumoral CD103intCD11b+ dendritic cell population
2023
·
Dimitris Stellas
, Sevasti Karaliota
, et al.
·
Cell Reports
·
10
PDF
Abstract 2727: Heterodimeric IL-15 (hetIL-15) affects conventional dendritic cells and a distinct novel dendritic cell population in different mouse cancer models of breast and pancreatic cancer
2021
·
Vasiliki Stravokefalou
, Dimitris Stellas
, et al.
·
Cancer Research
·
4
Abstract 3259: heterodimeric IL-15 monotherapy results in complete regression of EO771 murine breast tumors through cDC1-lymphocyte interactions and induction of antitumor immunity
2019
·
Dimitris Stellas
, Sevasti Karaliota
, et al.
·
Cancer Research
·
4
Mutual feedback regulation between Poly(A)-specific ribonuclease (PARN) and cognate microRNAs
2026
·
Athanasios Kyritsis
, Rafailia AA Beta
, et al.
·
Life Science Alliance
·
1
Abstract 6651: Combination of hetIL-15 with chemotherapy in triple negative breast and pancreatic cancer mouse models increases tumor necrosis and alleviates metastatic disease
2020
·
Dimitris Stellas
, Vasiliki Stravokefalou
, et al.
·
Cancer Research
·
1
Mechanism of Heterodimeric IL-15 in tumor reduction: Induction of myeloid-lymphoid cell interactions leads to IFN-γ dependent lymphocyte recruitment by dendritic cells into tumors
2020
·
George N Pavlakis
, Cristina Bergamaschi
, et al.
·
The Journal of Immunology
·
1
Abstract 3259: heterodimeric IL-15 monotherapy results in complete regression of EO771 murine breast tumors through cDC1-lymphocyte interactions and induction of antitumor immunity
2019
·
Dimitris Stellas
, Sevasti Karaliota
, et al.
·
Immunology
·
1
Abstract 4064: hetIL-15 and Fenofibrate combination alters the metabolic fitness of tumor-infiltrating CD8+T cells leading to TNBC tumor eradication in mice
2024
·
Dimitris Stellas
, Sevasti Karaliota
, et al.
·
Cancer Research
Synergy of heterodimeric IL-15 immunotherapy and a Fatty Acid Metabolism Modulator enhances intratumoral lymphocyte metabolism and eradicates EO771 murine breast tumors
2023
·
Sevasti Karaliota
, Dimitris Stellas
, et al.
·
The Journal of Immunology
PDF
Abstract 5082: Heterodimeric IL-15 (hetIL-15) immunotherapy synergizes with Fatty Acid Metabolism Modulator (FAMM) to eradicate TNBC EO771 murine tumors
2023
·
Sevasti Karaliota
, Dimitris Stellas
, et al.
·
Cancer Research
Abstract 2441: hetIL-15 decreases tumor cell dissemination and colonization and synergizes with chemotherapy and surgery to cure murine 4T1 breast tumors
2022
·
Vasiliki Stravokefalou
, Dimitris Stellas
, et al.
·
Cancer Research
Abstract 5603: Heterodimeric IL-15 (hetIL-15) immunotherapy reverses CD8+T cell metabolic dysfunction in murine breast tumors
2022
·
Dimitris Stellas
, Sevasti Karaliota
, et al.
·
Cancer Research
575 Regression by hetIL-15 monotherapy in different mouse breast cancer models correlates with intratumoral infiltration of a novel population of dendritic cells
2020
·
Sevasti Karaliota
, Dimitris Stellas
, et al.
·
Journal for ImmunoTherapy of Cancer
Abstract 5694: Complete regression of murine breast tumors by hetIL-15FC monotherapy correlates with infiltration by T, NK, cDC1 cells and a novel population of dendritic cells
2020
·
Sevasti Karaliota
, Dimitris Stellas
, et al.
·
Cancer Research
Regression of murine breast tumors after hetIL-15 monotherapy correlates with a novel population of intratumoral dendritic cells, in addition to increased infiltration of T, NK and cDC1 cells
2020
·
George N Pavlakis
, Sevasti Karaliota
, et al.
·
The Journal of Immunology
Show more works
View as search
Works count:
23
Citation count:
126
H-index:
4
I10-index:
4
Year
Topic
Type